Unveiling the science of drug development: strategies, successes, and challenges

M. Shakir Hussain; Ajit Kumar Mishra; Rishabh Pandey

doi:10.18203/2319-2003.ijbcp20252592

Authors

M. Shakir Hussain Department of Pharmacology, Autonomous State Medical College, Gonda, U. P., India
Ajit Kumar Mishra Department of Pharmacology, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, U. P. India
Rishabh Pandey Department of Pharmacology, Ram Manohar Lohia Institute of Medical Sciences, Lucknow, U. P., India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20252592

Keywords:

Drug development, Regulatory oversight, Preclinical research, Artificial intelligence, Emerging trends

Abstract

This abstract provides an in-depth exploration of drug development, from historical perspectives to modern challenges and emerging trends. It begins by tracing the evolution of drug development over centuries, highlighting the pivotal role of pharmacy and regulatory oversight. The abstract emphasizes the multifaceted nature of drug development, involving collaboration across scientific disciplines and various stages, from preclinical to post-market monitoring. The challenges inherent in drug development, such as high costs, lengthy timelines, and regulatory hurdles, are thoroughly examined. Despite these challenges, the abstract underscores the importance of drug development in addressing unmet medical needs and improving public health. Furthermore, the abstract delves into specific aspects of drug development, including preclinical research and discovery, clinical trial methodologies, and successes and challenges in the field. It also discusses emerging trends, such as precision medicine, digitalization, and the role of artificial intelligence and machine learning. Overall, this abstract provides a comprehensive overview of drug development, highlighting its significance, challenges, and future directions in advancing healthcare.

Metrics

Metrics Loading ...

References

Barrett JS. The History of Drug Development. In book Fundamentals of Drug Development. Wiley. 2022;5-27. DOI: https://doi.org/10.1002/9781119913276.ch1

Helen, Ethel, Edwards. Overview of Drug Development. 2022;3-15. DOI: https://doi.org/10.1201/9781003226857-2

Blass BE. Basic Principles of Drug Discovery and Development, 2nd edi, Academic Press Inc. 2021.

Bashir SF, Meena S, Kumar G. Basics of the Drug Development Process. In Current Trends in the Identification and Development of Antimicrobial Agents. Bentham Science Publisher. 2023;68-104. DOI: https://doi.org/10.2174/9789815080056123020006

Raguzin EV, Yudin MA, Glushenko DD, Vengerovich NG, Raguzina OG, Pechurina TB, et al. Analysis and Evaluation of Modern Approaches to Development of Medical Drugs Using Micro- and Nanotechnologies. I. P. Pavlov Russian Med Biological Herald. 2022;30(3):397-410. DOI: https://doi.org/10.17816/PAVLOVJ104787

Baile SB, Hadia R, Kardani S, Patel S, Patel K, Dash D. Anti-diabetic Plant Bioactive Compounds: Modern Drug Development from Traditional Herbal Medicine. In book: Multidisciplinary Approaches in Pharmaceutical Sciences. 2023;164-81. DOI: https://doi.org/10.9734/bpi/mono/978-81-19315-51-2/CH19

Singh N, Vayer P, Tanwar S, Poyet JL, Tsaioun K, Villoutreix BO. Drug discovery and development: introduction to the general public and patient groups. Front Drug Discovery. 2023;3:1201419. DOI: https://doi.org/10.3389/fddsv.2023.1201419

Kumar BH, Shaik FA, Prasanthi D. steps-in-the-process-of-new-drug-development. Paripex Indian J Res. 2021;1(1):47-9.

Zanders ED. Commercial aspects of drug development. In book: The Science and Business of Drug Discovery. 2023;319-40. DOI: https://doi.org/10.1007/978-3-030-57814-5_16

Poduri R. Pharmaceutical Industry, Academia, Regulatory Authorities and End User Collaboration, in book Successful Drug Discovery and Development. 2021;465-71. DOI: https://doi.org/10.1007/978-981-15-5534-3_17

Suntar I, Barreca D, Milella L. Methods for Preclinical Evaluation of Bioactive Natural Products. Bentham Science Publisher. 2023. DOI: https://doi.org/10.2174/97898151230431230101

Goel S, Kesh M. Target-Based Screening for Lead Discovery. In book: CADD and Informatics in Drug Discovery Publisher: Springer Nature Singapore. 2023;141-73. DOI: https://doi.org/10.1007/978-981-99-1316-9_7

Ansari MH. Preclinical Drug Development Process: Formulation and Development Aspects. Int J Med Pharmaceut Sci. 2023;13(03):1-10. DOI: https://doi.org/10.31782/IJMPS.2023.13301

Ramadan Q, Perinelli DR, Laura O, Sara B. Innovative approaches in drug discovery and development. Front Med Technol. 2023;5:1206088. DOI: https://doi.org/10.3389/fmedt.2023.1206088

Kapoor CM, Goyal R. Objectives and outcomes of a clinical trial. Indian J Anaesth. 2023;67(4):328-30. DOI: https://doi.org/10.4103/ija.ija_215_23

Reddy VS, Kumar CV, Venkatesh P. Phases of clinical trials: a review. Asian J Hospital Pharmacy. 2022;2(1):9-13.

Larry, William, Axmaker. Clinical trials. 2022;229-32. DOI: https://doi.org/10.1093/med/9780198779186.003.0016

Kim S. Overview of Clinical study design. Clin Exp Emerg Med. 2023;11(1):33-42. DOI: https://doi.org/10.15441/ceem.23.036

Herink MC, Irwin AN, Zumach GM. FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals. Pharmacotherapy. 2018;38(9):967-80. DOI: https://doi.org/10.1002/phar.2167

Hurley R. Government must boost spending on drug dependency services, says landmark review. BMJ. 2021;374:n1758. DOI: https://doi.org/10.1136/bmj.n1758

Nimkar S. Improving Patient Outcomes by Integration of Public Health and Mental Health.

Handbook on Optimizing Patient Care in Psychiatry. Edi 1st, Routledge. 2022;42-9.

Djordjević D, Paul A, McFadyen J, Anderson A. Ethical challenges and opportunities in the development and approval of novel therapeutics for rare diseases. J Med. 2023;7:275508342311775. DOI: https://doi.org/10.1177/27550834231177507

Iqra B, Usman DB, Syed AHM. New challenges in drug discovery. Novel Platforms for Drug Delivery Applications. Woodhead Publishing Series in Biomaterials. 2023;619-43. DOI: https://doi.org/10.1016/B978-0-323-91376-8.00021-5

Gummadi M, Koushik Y. Conventional Regulatory Submission Drawbacks and Strategies to Avoid Them. J Pharma Drug Regulatory Affairs. 2023;5(1):14-21. DOI: https://doi.org/10.46610/JPDRA.2023.v05i01.002

Timpe C, Stegemann S, Barrett A, Mujumdar S. Challenges and opportunities to include patient-centric product design in industrial medicines development to improve therapeutic goals. Brit J Clin Pharmacol. 2020;86(10):2020-7. DOI: https://doi.org/10.1111/bcp.14388

Sharlee, Climer. A machine-learning evaluation of biomarkers designed for the future of precision medicine. medRxiv. 2023. DOI: https://doi.org/10.1101/2023.07.09.23292430

Khadela A, Popat S, Ajabiya J, Valu D, Savale S, Chavda VP. AI, ML and Other Bioinformatics Tools for Preclinical and Clinical Development of Drug Products. Bioinformatics Tools for Pharmaceutical Drug Product Development. Wiley. 2023;255-84. DOI: https://doi.org/10.1002/9781119865728.ch12

Sobti RC, Kumari M, Singhla M, Bhandari R. Emerging Technologies: Gateway to Understand Molecular Insight of Diseases, Newer Drugs, Their Design, and Targeting. Biomedical Translational Research. Springer. 2022;3-15. DOI: https://doi.org/10.1007/978-981-16-9232-1_1